|
Name |
(2R)-2-[(1R)-4-methylcyclohex-3-en-1-yl]propanoic acid
|
Molecular Formula | C10H16O2 | |
IUPAC Name* |
(2R)-2-[(1R)-4-methylcyclohex-3-en-1-yl]propanoic acid
|
|
SMILES |
CC1=CC[C@@H](CC1)[C@@H](C)C(=O)O
|
|
InChI |
InChI=1S/C10H16O2/c1-7-3-5-9(6-4-7)8(2)10(11)12/h3,8-9H,4-6H2,1-2H3,(H,11,12)/t8-,9+/m1/s1
|
|
InChIKey |
QOGOGJNRMJOCKH-BDAKNGLRSA-N
|
|
Synonyms |
CHEBI:141292; (+)-(4R,8R)-Delta(1)-p-menthen-9-carboxylic acid; (2R)-2-[(1R)-4-methylcyclohex-3-en-1-yl]propanoic acid; (2R)-2-[(1R)-4-methylcyclohex-3-en-1-yl]propionic acid
|
|
CAS | NA | |
PubChem CID | 131142768 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 168.23 | ALogp: | 2.2 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 12 | QED Weighted: | 0.643 |
Caco-2 Permeability: | -4.695 | MDCK Permeability: | 0.00002200 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.016 | 20% Bioavailability (F20%): | 0.011 |
30% Bioavailability (F30%): | 0.008 |
Blood-Brain-Barrier Penetration (BBB): | 0.693 | Plasma Protein Binding (PPB): | 94.33% |
Volume Distribution (VD): | 0.504 | Fu: | 5.77% |
CYP1A2-inhibitor: | 0.049 | CYP1A2-substrate: | 0.223 |
CYP2C19-inhibitor: | 0.025 | CYP2C19-substrate: | 0.517 |
CYP2C9-inhibitor: | 0.018 | CYP2C9-substrate: | 0.916 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.215 |
CYP3A4-inhibitor: | 0.013 | CYP3A4-substrate: | 0.077 |
Clearance (CL): | 6.025 | Half-life (T1/2): | 0.86 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.546 |
Drug-inuced Liver Injury (DILI): | 0.191 | AMES Toxicity: | 0.002 |
Rat Oral Acute Toxicity: | 0.065 | Maximum Recommended Daily Dose: | 0.053 |
Skin Sensitization: | 0.465 | Carcinogencity: | 0.714 |
Eye Corrosion: | 0.933 | Eye Irritation: | 0.986 |
Respiratory Toxicity: | 0.141 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001066 | 0.439 | D03KEK | 0.267 | ||||
ENC000555 | 0.439 | D09PUL | 0.250 | ||||
ENC000511 | 0.419 | D08QGD | 0.243 | ||||
ENC001296 | 0.386 | D0I0EG | 0.232 | ||||
ENC001455 | 0.339 | D06PSS | 0.231 | ||||
ENC002339 | 0.333 | D0DZ3X | 0.227 | ||||
ENC001981 | 0.327 | D08HZC | 0.205 | ||||
ENC003255 | 0.327 | D06YPU | 0.203 | ||||
ENC001641 | 0.327 | D0B5LF | 0.203 | ||||
ENC001903 | 0.327 | D01CKY | 0.202 |